MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2023 International Congress

    A comparative analysis of vegetative disorders in Parkinson`s disease and vascular parkinsonism.

    R. Juraev, R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: Comparative analysis of vegetative disorders (VD)  in Parkinson's disease and vascular parkinsonism. Background: Vegetative disorders (VD) are one of the most common nonmotor disorders…
  • 2023 International Congress

    Effect of Best Practice Advisory on the administration of contraindicated medications to hospitalized patients with Parkinson’s disease and related disorders

    N. Chunga, K. Amodeo, M. Braun, B. Valdovinos, I. Richard (Rochester, USA)

    Objective: To determine if a best practice advisory (BPA) reduced the orders and administration of contraindicated dopamine blocking agents (DBA) to hospitalized patients with Parkinson’s…
  • 2023 International Congress

    Narrative review of the efficacy of the efficacy of transcranial magnetic stimulation with patients with Parkinson disease.

    A. Elaraby, M. Shaien (Gizah, Egypt)

    Objective: To evaluate the efficacy of transcranial magnetic stimulation with patients with Parkinson diseases. Background: Parkinson's disease is one of the most common causes of…
  • 2023 International Congress

    Asymmetric and profound nigrostriatal dopaminergic dysfunction in Parkinson’s disease with preceding REM sleep behavior disorders

    KA. Woo, HJ. Chang, JY. Joo, JH. Shin, SY. Kim, SM. Lee, BR. Jin, HY. Jeon, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: To investigate the differences in the pattern of nigrostriatal and pontine monoaminergic degeneration patients with de novo Parkinson's disease (PD), stratified by the presence…
  • 2023 International Congress

    Classification and genotype-phenotype relationships of GBA1 variants and Parkinson’s disease: MDSGene Systematic Review

    T. Usnich, M. Rossi, S. Schaake, N. Schell, J. Böhm, N. Steffen, C. Krüger, R. Alcalay, K. Lohmann, C. Klein (Lübeck, Germany)

    Objective: To provide a comprehensive and systematic literature review of variants in the glucocerebrosidase 1 gene (GBA1) linked to Parkinson’s disease (PD). Background: Approximately 10% of patients with PD…
  • 2023 International Congress

    Bowel symptoms and management practices in Parkinson’s disease and related conditions: results from the PRIME-UK study.

    C. Thomas, E. Tenison, K. Lloyd, M. Smith, Y. Ben-Shlomo, E. Henderson (Gloucestershire, United Kingdom)

    Objective: To describe bowel symptoms and constipation management practices in a large, representative cross-sectional study of Parkinson’s and related disorders. Background: Bowel symptoms, particularly constipation,…
  • 2023 International Congress

    The significance of myocardial infarction as a developmental factor in parkinsonism and vascular parkinsonism

    DT. Akramova, GS. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: to study the significance of myocardial infarction as a developmental factor in parkinsonism and vascular parkinsonism in Uzbekistyan Background: The prevalence of Parkinson's disease…
  • 2023 International Congress

    Machine Learning Model for Prediction of acute orthostatic hypotension after levodopa administration

    Z. Liu, SN. Lin, ZL. Chen, Y. Ling, T. Feng (Beijing, China)

    Objective: The aim of this study is to develop and validate a prediction model of AOHPL to facilitate physicians in identifying patients at higher probability…
  • 2023 International Congress

    Narcolepsy type 1, supranuclear vertical gaze palsy, and agrypnia excitata in a patient with anti-Ma associated encephalitis.

    C. Espinoza-Vinces, A. Horrillo, R. Villino, A. Solis, P. Domínguez, J. Arbizu, MR. Luquin, E. Urrestarazu, I. Avilés-Olmos (Pamplona, Spain)

    Objective: To describe a case of a patient with narcolepsy type 1, supranuclear vertical gaze palsy, and agrypnia excitata, who presented with anti-Ma encephalitis. Background:…
  • 2023 International Congress

    Hydrocephalus associated with Chiari-I malformation presenting with parkinsonism and dystonia

    A. Maheshwary, L. Wolansky, B. Rodrigues, K. Bulsara, D. Karimeddini, B. Springate, N. Prakash (Hartford, USA)

    Objective: To provide a case description of dystonia-predominant parkinsonism due to underlying hydrocephalus associated with CIM in an adult. Background: Hydrocephalus is estimated to be…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley